IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $716,000 | +6.2% | 15,140 | +35.8% | 0.07% | +84.6% |
| Q4 2019 | $674,000 | -0.1% | 11,150 | -1.1% | 0.04% | +21.9% |
| Q3 2019 | $675,000 | -28.9% | 11,270 | -23.7% | 0.03% | -23.8% |
| Q2 2019 | $950,000 | +24.2% | 14,780 | +56.7% | 0.04% | +40.0% |
| Q1 2019 | $765,000 | -44.4% | 9,430 | -71.4% | 0.03% | -28.6% |
| Q2 2018 | $1,376,000 | -19.7% | 33,010 | -15.0% | 0.04% | -23.6% |
| Q1 2018 | $1,713,000 | -12.3% | 38,855 | 0.0% | 0.06% | -8.3% |
| Q4 2017 | $1,954,000 | -0.8% | 38,855 | 0.0% | 0.06% | -3.2% |
| Q3 2017 | $1,970,000 | +39.4% | 38,855 | +39.9% | 0.06% | +63.2% |
| Q2 2017 | $1,413,000 | – | 27,770 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |